Heavy! China has officially launched the emergency use of the new crown vaccine.

On July 22nd, Zheng Zhongwei, director of the Science and Technology Development Center of the National Health and Health Commission and head of the research team of the Joint Prevention and Control Mechanism of the State Council, said in the program that China had officially launched the emergency use of the new crown vaccine on July 22nd.
The Vaccine Management Law clearly stipulates that in the event of a particularly serious public health event, the Application for Emergency Use of Vaccines by the National Health and Health Commission shall be made by experts organized by the State Drug Administration and agreed that the National Health and Health Commission shall make emergency use of the vaccine within a certain scope and within a certain time limit.
aim is to establish an immunization barrier in the special population such as medical personnel, epidemic prevention personnel, border control personnel and basic operators of the city, and the operation of the whole city will be stable.
phase III clinical trial of the new crown vaccine into the group of more than 20,000 people Phase III clinical research, is related to the vaccine can be listed for large-scale population vaccination is an important step.
Yang Xiaoming, chairman of China Biopharmaceuser China and chief scientist of the national "863" vaccine program, said that on June 23rd, the launch ceremony of china Bio-New Coronary Inactivated Vaccine International Clinical (Phase III. Phase III. ) in the United Arab Emirates was held simultaneously by video conferencing in Beijing, Wuhan and Abu Dhabi, United Arab Emirates.
so far, the number of people vaccinated in the group has exceeded 20,000 and has created several world firsts;
August 20th and August 21st, China National Pharmaceutical Group signed cooperation agreements and held a launch ceremony with Peru, Morocco and Argentina on phase III clinical trials of the new coronary inactivated vaccine.
this marks a comprehensive speed-up of phase III clinical trials of China's new bio-crown inactivated vaccine.
more sample size and clinical trial data from different regions will greatly enhance the market process of the new corona inactivated vaccine and contribute China's wisdom and strength to the health and well-being of the community of human destiny and the people of the world.
a small new crown vaccine, gathered the efforts, wisdom and sweat of countless Chinese researchers.
, it means life, health, hope, and the future.
on the road to creating vaccines, a global public health product, China's vaccine pioneers are moving at full speed with responsibility and mission.
source: CCTV.com.